Reports for SANDOZ RIVASTIGMINE
Brand name
SANDOZ RIVASTIGMINE
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02324571 |
Ingredients
RIVASTIGMINE |
Ingredient Strength
3 MG |
ATC Code
N06DA |
ATC Descriptor
ANTI-DEMENTIA DRUGS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 4X14/bl | Resolved | 2019-02-04 | 2019-04-10 | 74710 |
| SANDOZ RIVASTIGMINE | 100HGC BO | Resolved | 2021-11-15 | 2021-12-20 | 149283 |
| SANDOZ RIVASTIGMINE | 56HGC | Resolved | 2022-02-01 | 2022-03-11 | 154015 |
| SANDOZ RIVASTIGMINE | 100HGC | Resolved | 2023-03-13 | 2023-04-05 | 186981 |
| SANDOZ RIVASTIGMINE | 100HGC | Resolved | 2024-09-16 | 2024-12-11 | 237764 |
| SANDOZ RIVASTIGMINE | 56HGC | Resolved | 2024-10-28 | 2024-12-11 | 241411 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 56HGC | Discontinued | 2024-12-10 | 2024-12-11 | 245273 |
| SANDOZ RIVASTIGMINE | 100HGC BO | Discontinued | 2024-12-10 | 2024-12-11 | 245276 |
Showing 1 to 2 of 2